Cibc World Markets Corp Amgen Inc Transaction History

Cibc World Markets Corp

$15 Billion
Q2 2024

A detailed history of Cibc World Markets Corp transactions in Amgen Inc stock. As of the latest transaction made, Cibc World Markets Corp holds 203,233 shares of AMGN stock, worth $65.6 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

203,233

Previous 174,232 16.65%

Holding current value

$65.6 Million

Previous $49.5 Million 28.19%

% of portfolio

0.42%

Previous 0.33%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $7.62 Million - $9.26 Million	29,001 Added 16.65%	203,233 $63.5 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $5.57 Million - $6.73 Million	-20,729 Reduced 10.63%	174,232 $49.5 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $16.5 Million - $18.6 Million	64,376 Added 49.3%	194,961 $56.2 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $5.08 Million - $6.3 Million	23,218 Added 21.62%	130,585 $35.1 Million
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $12.9 Million - $15.3 Million	60,415 Added 128.67%	107,367 $23.8 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $4.99 Million - $6.09 Million	-22,122 Reduced 32.03%	46,952 $11.4 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $8.49 Million - $10.8 Million	37,079 Added 115.89%	69,074 $18.1 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $9.5 Million - $10.7 Million	-42,330 Reduced 56.95%	31,995 $7.21 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $45.3 Million - $50.4 Million	-196,262 Reduced 72.53%	74,325 $18.1 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $9.06 Million - $10 Million	41,330 Added 18.03%	270,587 $65.4 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $42.6 Million - $48.8 Million	-214,303 Reduced 48.31%	229,257 $51.6 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $43.7 Million - $51.2 Million	205,728 Added 86.5%	443,560 $94.3 Million
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $5.58 Million - $6.2 Million	23,908 Added 11.18%	237,832 $58 Million
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $23.2 Million - $27 Million	-104,485 Reduced 32.81%	213,924 $53.2 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $23 Million - $27.4 Million	106,339 Added 50.14%	318,409 $73.2 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $27.3 Million - $30.3 Million	116,247 Added 121.31%	212,070 $53.9 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $638,332 - $783,321	3,227 Added 3.49%	95,823 $22.6 Million
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $4.77 Million - $6.33 Million	-26,179 Reduced 22.04%	92,596 $18.8 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $22.4 Million - $28.8 Million	-118,267 Reduced 49.89%	118,775 $28.6 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $17 Million - $20.4 Million	97,673 Added 70.08%	237,042 $45.9 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $1.6 Million - $1.87 Million	-9,589 Reduced 6.44%	139,369 $25.7 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $37.8 Million - $42.7 Million	-209,225 Reduced 58.41%	148,958 $28.3 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $1.89 Million - $2.21 Million	-10,621 Reduced 2.88%	358,183 $69.7 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $40.9 Million - $46.1 Million	220,792 Added 149.17%	368,804 $76.4 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $2.64 Million - $2.97 Million	-15,898 Reduced 9.7%	148,012 $27.3 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $8.74 Million - $10.2 Million	-51,605 Reduced 23.94%	163,910 $27.9 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $8.27 Million - $9.24 Million	49,016 Added 29.44%	215,515 $37.5 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $27.9 Million - $31.8 Million	166,499	166,499 $31 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Account

Cibc World Markets Corp Amgen Inc Transaction History